Therefore, although the increases in cell apoptosis and reduction in cell growth in NDV-D90-treated gastric cancer cells seemingly resulted from augmentation of apoptosis-associated p38 signaling and suppression of proliferation-associated ERK1/2 and Akt signaling, these signaling pathways also have effects on cell mobility and invasion potential. The gene discussed is MAPK3; the disease is gastric cancer.